FDA suspends license for Valneva’s chikungunya shot
Written by
BioPharma Dive
Published
0
comments
0
min
The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to conclude the vaccine is no longer safe for its intended use.